Wilson Sonsini - ECP

Global Generics

Our Industry

Today’s generic pharmaceutical market is high paced and rapidly growing. With change comes increasing regulation and drive to support research and development, which Wilson Sonsini has deep expertise navigating for its clients. Through specialized support and industry knowledge, our attorneys can assemble a team to bring pharmaceutical offerings to global markets.

Industry Highlights

Celebrating our
founders’ successes

Global Generics Industry


Mylan Set to Acquire Aspen Pharmaceutical's Thrombosis Business for $756 Million

Generics and Specialty Pharmaceuticals


Pfenex Acquired by Ligand Pharmaceuticals for $566 Million

Biotechnology (Protein Therapies)


on this

See all ECP attorneys


See all ECP attorneys

recent news

we want to share
with you

Life Sciences COVID-19 Toolkit

Life Sciences COVID-19 Toolkit

Industry alerts03/26/20
See all news
See all news

other industries

we have covered

Copyright © 2021 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.

We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content. For more information or to opt-out, visit our privacy policy.